ABSTRACT
As one whose family has been affected by factor V Leiden since 1980, the author knows firsthand the impact of this disease process on patients, outcomes, and practice. In today's healthcare environment, genetic screening for the factor V mutation is routine among pregnant women. Preoperative testing is often done on those "at risk." This article addresses the genetics, the occurrence, the treatment, and practice implications.